| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.39B | 34.69B | 31.28B | 28.75B | 26.91B | 27.73B |
| Gross Profit | 10.67B | 10.11B | 8.75B | 8.06B | 6.98B | 6.90B |
| EBITDA | 4.66B | 4.61B | 3.43B | 1.93B | 1.82B | 2.00B |
| Net Income | 2.92B | 2.88B | 2.04B | 1.16B | 1.25B | 1.34B |
Balance Sheet | ||||||
| Total Assets | 18.51B | 18.78B | 17.92B | 17.70B | 20.77B | 20.89B |
| Cash, Cash Equivalents and Short-Term Investments | 10.93B | 11.63B | 11.01B | 10.60B | 13.69B | 14.30B |
| Total Debt | 64.00M | 96.00M | 12.00M | 2.00B | 5.00B | 5.00B |
| Total Liabilities | 6.25B | 5.61B | 4.63B | 5.73B | 8.79B | 8.82B |
| Stockholders Equity | 12.02B | 12.91B | 12.97B | 11.97B | 11.97B | 12.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.69B | 3.09B | 1.02B | 841.00M | 2.21B |
| Operating Cash Flow | 0.00 | 3.97B | 3.30B | 1.51B | 1.46B | 2.69B |
| Investing Cash Flow | 0.00 | 110.00M | -733.00M | -594.00M | -838.00M | -373.00M |
| Financing Cash Flow | 0.00 | -2.97B | -3.12B | -4.21B | -1.41B | 2.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥258.25B | 16.33 | 28.98% | 5.57% | 4.09% | 17.10% | |
83 Outperform | ¥88.87B | 29.69 | ― | 3.53% | 9.97% | 22.68% | |
79 Outperform | ¥121.79B | 13.47 | ― | 7.51% | 8.28% | -36.32% | |
75 Outperform | ¥141.99B | 20.10 | ― | 2.38% | 20.17% | 32.32% | |
66 Neutral | ¥529.67B | 15.57 | 19.18% | 3.59% | 6.95% | 13.63% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥70.89B | -1,275.30 | -6.02% | 0.77% | -9.70% | -108.59% |